Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217132 · ClinicalTrials.gov registry record
Clinical Investigation Plan - Post-market Clinical Follow-up Study Collagen Dura Membrane - Suturable
A clinical trial, sponsored by Collagen Matrix.
- Not yet
- Registry status
- 54
- Enrollment target
NCT07217132: Clinical Trial study, sponsored by Collagen Matrix.
NCT07217132 is a clinical trial that has not yet begun recruiting, run by Collagen Matrix. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07217132 has not yet begun recruiting, sponsored by Collagen Matrix.
- NOT YET RECRUITING
- Registry status
- 54 participants
- Enrollment target
Study Summary
Monitoring the use of Collagen Dura Membrane - Suturable (DMS) in the post-market phase
Primary Outcome
Rate of adverse events related to subject device and requiring surgical intervention.
Interventions
- OTHER Post-market Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2027-09 |
What is known before NCT07217132 opens enrollment
NCT07217132 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Post-market Study is the first listed.
NCT07217132 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07217132 about?
NCT07217132 is a clinical study titled "Clinical Investigation Plan - Post-market Clinical Follow-up Study Collagen Dura Membrane - Suturable". Monitoring the use of Collagen Dura Membrane - Suturable (DMS) in the post-market phase
What is the current status of trial NCT07217132?
This trial is currently not yet recruiting. The enrollment target is 54 participants. The study started on 2025-12-01. Estimated completion is 2027-09.
What interventions are being tested in trial NCT07217132?
The interventions under investigation include: Post-market Study (OTHER).
Who is sponsoring clinical trial NCT07217132?
This trial is sponsored by Collagen Matrix, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI